In accordance with the ubiquitination outcomes, degradation kinetic experiments reflected that in contrast to control cells, the exogenous FBXO45 half-life in the TNBC cancer cells overexpressing RBX1 was markedly lower (Figure 6J, 6K). This evidence concerns the gene RBX1 and cancer.